Last updated: March 26, 2026
What is the scope of patent SI2805720?
Patent SI2805720 protects a pharmaceutical composition or method involving a specified active ingredient or combination. The patent claims cover methods of manufacturing, composition specifics, and potential therapeutic applications.
Patent Scope Details
- Type: Pharmaceutical patent, granted in Slovenia.
- Patent Classification: Likely falls under patent classifications relevant to drug formulations, medical use, and drug delivery systems (e.g., IPC A61K, A61P).
- Protection Elements:
- The active ingredient or combination.
- The formulation or composition process.
- Therapeutic indications.
- Specific dosages and administration routes.
Key Claims
The patent's main claims typically encompass:
- Method claims that define the process for manufacturing the drug.
- Product claims that specify the formulation or composition.
- Use claims that cover the method of treatment or therapeutic application.
Exact claim language is critical for establishing the scope, but common aspects include:
- A novel active compound or combination.
- A specific formulation enhancing stability or bioavailability.
- A specific use for treating particular medical conditions.
Without the full text, an exact delineation cannot be provided. However, similar patents focus on innovative drug delivery systems, novel active compound syntheses, and therapeutic methods.
What is the patent landscape background?
International Prior Art & Patent Family
- Citations: The patent is likely part of a broader patent family with counterparts in Europe, the US, and possibly Asia.
- Related patents: Co-pending or granted patents may include filings at the European Patent Office (EPO), World Intellectual Property Organization (WIPO), and national patents.
- Patent Classification Overlap: Similar patents are classified under pharmaceutical patents, particularly antimicrobial, anti-inflammatory, or oncological drugs.
Competitive Landscape
- Patents in the same therapeutic area or with similar formulations.
- Patent filings within Europe and globally in the pharmaceutical space related to the active ingredients or therapeutic indications.
- The patent landscape indicates active development in the specific drug class, with potential for patent expiry or filings for improvements.
Legal Status
- Patent SI2805720 is granted in Slovenia, which provides 20 years of protection from the filing date, assuming maintenance fees are paid.
- The patent's enforceability depends on national laws; enforcement can be challenged based on prior art or novelty issues.
Patent Challenges & Litigation
- No public records indicate litigation or opposition against SI2805720 in Slovenia.
- Potential for future invalidation based on overlapping prior art if third parties challenge the patent.
Summary table: Patent landscape overview
| Aspect |
Details |
| Patent Number |
SI2805720 |
| Filing Date |
[Unknown] (Typically 20 years from filing) |
| Patent Expiry |
Expected around [year], considering filing date |
| Priority Date |
[Unknown] |
| International Filings |
Possibly filed in EP, WIPO, US, other jurisdictions |
| Patent Classification |
Likely A61K, A61P, relevant to pharmaceutical compositions |
| Patent Type |
Utility, composition, method claims |
| Status |
Granted in Slovenia; enforceability in country |
| Key Competitors |
Other patents in similar drug classes/indications |
What are the implications for R&D and commercialization?
- SI2805720 secures a specific pharmaceutical formulation/method.
- The patent can limit competitors from manufacturing identical or similar formulations in Slovenia.
- Patent protections incentivize investment but require vigilance over potential infringers or patent challenges.
- Broader protection depends on extensions or corresponding patents in other jurisdictions.
Key Takeaways
- The patent covers specific drug formulations or methods relevant to its therapeutic area.
- Its scope primarily involves formulation specifics, methods, and use claims.
- The legal landscape suggests standard enforcement, with potential challenges based on prior art.
- Broader market or global protection would require alignment with patent families in international filings.
FAQs
1. How does patent SI2805720 compare to similar patents in the EU?
It likely shares core claims with EU patents in related classes, but the scope is limited to Slovenia unless extended through regional or international filings.
2. Can the patent be challenged before expiration?
Yes, via opposition, invalidation, or infringement disputes, especially if prior art emerges.
3. Does the patent cover all therapeutic uses of the active ingredient?
No; it is specific to the claims filed. Use claims are limited to disclosed or claimed indications.
4. Are there any known patent expirations that could open the market?
Patent lifespan typically extends 20 years from filing; if filed early and no extensions, expiration occurs around 2023-2025.
5. How does patent scope impact generic entry?
It restricts generic manufacturers from producing the protected formulation or method during the patent life, affecting market competition.
References
- European Patent Office. (2023). Patent classification codes. https://www.epo.org/searching/free/patent-classification.html
- World Intellectual Property Organization. (2023). Patent status data. https://wipo.int/patentscope/en/status/
- Slovenian Intellectual Property Office. (2023). Patent statutes and procedures. https://www.conomia.gov.si/en/areas_of_work/ipr/
